Neuro-interventional Devices Market to Surpass US$ 3,202.9 Million by 2028 - Coherent Market Insights

Global Neuro-interventional Devices Market, by Product Type (Embolization Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy, Flow Disruption, Flow Diverters, Intrasaccular Devices, Liquid Embolic Coils, Balloons, and Stent Retrievers), by Technique (Neurothrombectomy Procedure, Cerebral Angiography, Stenting, Coiling Procedures, and Flow Disruption), by End User (Hospitals, Clinics, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 2,216.7 Mn in 2021 and is expected to exhibit a CAGR of 5.0% during the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.

Increasing focus of major market players on product approvals is expected to boost the market growth during the forecast period. For instance, in April 2020, Cerus Endovascular Ltd., a commercial stage medical device company, announced that it received CE Mark approval for its 021-inch Contour Neurovascular System. It is a lower profile system which is used for the treatment of saccular intracranial aneurysms. The Contour Neurovascular System is a unique, fine mesh braid that is installed across the neck of the aneurysm sac and it helps in providing a combination of flow disruption and flow diversion by a single device implant.

Global Neurointerventional Devices Market – Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 virus has spread rapidly and infected millions of people worldwide. In March 2020, the World Health Organization (WHO) announced it as a public health emergency and declared it as a pandemic. Many countries such as the U.S., Germany, France, India, and Japan among others have taken significant steps to combat the COVID-19 epidemic.

According to the article published in the Journal of Neurointerventional Surgery, in June 2020, due to the pandemic, neurointerventional physicians are facing two major challenges such as the neurological disease treatment along with combating COVID-19 infection spread. Also, the Chinese Federation of Interventional and Therapeutic Neuroradiology (CFITN) and the International Society for Neurovascular Disease (ISNVD) have called the neuro-interventional specialists from various departments such as neurosurgery, neurology, and interventional radiology in order to discuss and compile the expert consensus based on their working experience in fighting against the COVID-19 epidemic and related regulations for performing neuro-interventional procedures issued by National Health Commission.

Browse 32 Market Data Tables and 35 Figures spread through 312 Pages and in-depth TOC on “Global Neurointerventional Devices Market”- Forecast to 2028, Global Neuro-interventional Devices Market, by Product Type (Embolization Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy, Flow Disruption, Flow Diverters, Intrasaccular Devices, Liquid Embolic Coils, Balloons, and Stent Retrievers), by Technique (Neurothrombectomy Procedure, Cerebral Angiography, Stenting, Coiling Procedures, and Flow Disruption), by End User (Hospitals, Clinics, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in the Global Neurointerventional Devices Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/neurointerventional-devices-market-3200

Rising technological advancements in neuro-interventional devices is expected to boost the neuro-interventional devices market growth during the forecast period. For instance, in November 2019, Corindus, a Siemens Healthineers Company, announced the launch of its CorPath GRX System. It was used to complete the first-inhuman robotic-assisted neurovascular intervention. The robotic and stent-assisted aneurysm coiling device is used in new interventional treatment for patients with neurovascular disease.

Key Takeaways of the Global Neurointerventional Devices Market:

• The global neuro-interventional devices market is expected to exhibit a CAGR of 5.0% during the forecast period, owing to the increasing focus of key players on inorganic growth strategies such as product launch, acquisition, merger, and collaboration, which is expected to drive the growth of the global neuro-interventional devices market. For instance, in April 2019, Insera Therapeutics, Inc., a medical devices company received CE Mark approval for the product, CLEAR Aspiration System. It is used in patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease, and venous sinus thrombosis, which involves staged aspiration through a balloon guide or guide catheter within the neck arteries.
• Among product type, embolic coils segment is estimated to account for the largest market share in the global neuro-interventional devices market in 2021, owing to increasing new product launches. For instance, in January 2018, Cerenovus, a part of Johnson & Johnson Medical Devices Companies, launched the Galaxy G3 mini coil, which is the smallest and softest embolic finishing coil, for the endovascular treatment of cerebral aneurysms and hemorrhagic stroke. This new coil is the latest addition to the GALAXY G3 Microcoil range of filling and finishing coils that consist of stretch resistance technology and a proprietary complex random loop design.
• Among technique, coiling procedures segment is estimated to account for the largest market share in the global neuro-interventional devices market in 2021. Manufacturers such as Penumbra Inc. a medical device company and Stryker Corporation a medical technologies company, have detachable coils in their product portfolio, which are used for neurovascular intervention. For instance, Stryker Corporation offers GDC 360° Detachable coils for embolization of intracranial aneurysms.
• Among end user, hospitals segment is estimated to account for the largest market share in the global neuro-interventional devices market in 2021. Increasing prevalence of neurological problems lead to hospitalizations of patients with neurological disorders. For instance, in 2018, according to a survey conducted by the American Hospital Association, around 36,241,815 hospitalizations were reported in around 6,090 hospitals in the U.S.
• Among regions, North America is estimated to hold dominant position in the global neuro-interventional devices market in 2021, owing to the initiatives and funding by governments in the region. For instance, in February 2018, the government of Canada and Brain Canada, a national charitable organization, announced a grant of US$ 10 million for establishment of the Canadian Open Neuroscience Platform (CONP). CONP is a partnership of 15 universities, which will focus on the development of devices for treatment of neurological disorders.
• Major players operating in the global neuro-interventional devices market include Penumbra, Inc., Stryker Corporation, Medtronic PLC., Johnson & Johnson Services, Inc., Terumo Corporation, Insera Therapeutics Inc., Anaconda Biomed S.L., and Perflow Medical Ltd.